Published in Lipids Health Dis on October 20, 2005
Delta-6-desaturase gene polymorphism is associated with lipoprotein oxidation in vitro. Lipids Health Dis (2013) 0.78
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol (1981) 4.48
Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun (1989) 2.81
Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res (1982) 2.71
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta (1990) 2.42
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med (1993) 2.20
High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A (1992) 2.15
Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol (2003) 1.93
HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis (1995) 1.48
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest (1993) 1.29
High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci U S A (1991) 1.17
Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A (1992) 1.14
Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol (1997) 1.09
Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett (1994) 1.07
Letter: Serum high-density-lipoprotein and coronary heart-disease. Lancet (1976) 1.03
Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol (2002) 1.00
Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis (2002) 0.98
Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes (1994) 0.98
Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb (1992) 0.97
Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J Lipid Res (1995) 0.95
Effect of ageing and caloric restriction on specific markers of protein oxidative damage and membrane peroxidizability in rat liver mitochondria. Mech Ageing Dev (2004) 0.90
Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr (1995) 0.87
Factors affecting resistance of low density lipoproteins to oxidation. Lipids (1996) 0.86
In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis (1994) 0.86
Kinetic analysis of copper-induced peroxidation of LDL. Biochim Biophys Acta (1998) 0.85
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Artery Dis (1993) 0.85
Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radic Biol Med (1993) 0.83
Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr (1993) 0.81
Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm. Atherosclerosis (1999) 0.81
Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem (2000) 0.81
Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation. Free Radic Biol Med (2000) 0.81
Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients. Clin Chim Acta (1998) 0.80
Dietary habits affect the susceptibility of low-density lipoprotein to oxidation. Eur J Clin Nutr (1999) 0.80
HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures. J Lipid Res (1995) 0.79
Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem Biophys Res Commun (1995) 0.79
Effects of a high polyunsaturated fat diet and vitamin E supplementation on high-density lipoprotein oxidation in humans. Atherosclerosis (2001) 0.79
Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein by cultured fibroblasts. Biochim Biophys Acta (1989) 0.77
Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes. Diabetes Metab Res Rev (2001) 0.77
In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism (2004) 0.77
Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation. J Heart Lung Transplant (2004) 0.76
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65
When do social inequalities in C-reactive protein start? A life course perspective from conception to adulthood in the Cardiovascular Risk in Young Finns Study. Int J Epidemiol (2007) 1.74
Matrix metalloproteinase-9 is elevated in serum of alcohol abusers. Eur J Clin Invest (2002) 1.55
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem (1999) 1.43
Rapid identification of angiotensin-converting enzyme genotypes by capillary electrophoresis. Clin Chem (1997) 1.43
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry (1999) 1.30
Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem (1998) 1.22
Paraoxonase gene polymorphisms and coronary reactivity in young healthy men. J Mol Med (Berl) (2001) 1.21
Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation (1999) 1.21
Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev (2006) 1.14
New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett (1997) 1.14
Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol (2005) 1.14
Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol (1999) 1.10
Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res (1996) 1.10
Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis. Ann Neurol (1999) 1.09
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. Diabet Med (2004) 1.08
Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis (1995) 1.04
Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest (1994) 1.04
Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol (2001) 1.04
Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2007) 1.03
The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease. Ann Neurol (1998) 1.03
Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther (2007) 1.01
Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett (2000) 1.00
Pulse wave velocity reference values in healthy adults aged 26-75 years. Clin Physiol Funct Imaging (2007) 1.00
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm (Vienna) (2007) 0.99
Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med (2009) 0.98
Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett (1990) 0.98
Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest (2007) 0.97
Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Genet (2009) 0.95
Identification of different bacterial DNAs in human coronary arteries. Eur J Clin Invest (2005) 0.94
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest (2002) 0.94
Sedentary behaviours and obesity in adults: the Cardiovascular Risk in Young Finns Study. BMJ Open (2013) 0.94
Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg (1998) 0.93
Serum sialic acid in a random sample of the general population. Clin Chem (1999) 0.93
Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2012) 0.93
Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey. Clin Exp Immunol (2011) 0.92
Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology (Oxford) (2004) 0.92
Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis (2009) 0.91
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest (2008) 0.91
Trends in serum lipid levels during 1980-1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol (1997) 0.91
Interleukin-6 -174G/C polymorphism and longevity: a follow-up study. Mech Ageing Dev (2005) 0.90
The association between cigarette smoking and carotid intima-media thickness is influenced by the -930A/G CYBA gene polymorphism: the Cardiovascular Risk in Young Finns Study. Am J Hypertens (2008) 0.90
Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J Neural Transm (Vienna) (2004) 0.89
Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ (1999) 0.89
Late carotid restenosis: aetiologic factors for recurrent carotid artery stenosis during long-term follow-up. Eur J Vasc Surg (1989) 0.89
Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ (2000) 0.88
Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet (2005) 0.88
Phenotype expression in familial combined hyperlipidemia. Atherosclerosis (1997) 0.88
Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. Atherosclerosis (2001) 0.87
Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurol Scand (2003) 0.87
Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. J Intern Med (2009) 0.87
Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res (2000) 0.87
Genome-wide association study does not reveal major genetic determinants for anti-cytomegalovirus antibody response. Genes Immun (2011) 0.87
No relation between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet (1998) 0.87
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) (2004) 0.87
Are body mass index, waist circumference and waist-to-hip ratio associated with leptin in 90-year-old people? Eur J Clin Nutr (2013) 0.87
Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis (1996) 0.86
A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. Transl Psychiatry (2012) 0.86
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res (1996) 0.86
The effect of proteoglycans, collagen and lysyl oxidase on the metabolism of low density lipoprotein by macrophages. Atherosclerosis (1986) 0.86
C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2007) 0.85
Overweight in childhood and bone density and size in adulthood. Osteoporos Int (2011) 0.85
Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett (1994) 0.85
Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Arch Neurol (2000) 0.85
High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the Cardiovascular Risk in Young Finns Study. Free Radic Res (2014) 0.84
Antibodies to cytoskeletal proteins in sera of patients with angiographically assessed coronary artery disease. Atherosclerosis (1993) 0.84
The hepatic lipase gene C-480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study. Eur J Clin Invest (2007) 0.84
Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2009) 0.84
Rapid apolipoprotein E genotyping from mailed buccal swabs. J Neurosci Methods (1998) 0.84
Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev (2007) 0.83
Comparison of indirect diagnostic methods for hypolactasia. Scand J Gastroenterol (1988) 0.83
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging (1997) 0.83
Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids. J Chromatogr B Biomed Sci Appl (2001) 0.83
Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest (2000) 0.83
Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2007) 0.83
A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis. Am J Gastroenterol (2001) 0.83
Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol. Pharmacogenetics (2001) 0.83
Dependence between apolipoprotein E phenotypes and temperament in children, adolescents, and young adults. Psychosom Med (1993) 0.82
Association of neuropeptide y polymorphism with the occurrence of type 1 and type 2 alcoholism. Alcohol Clin Exp Res (2001) 0.82
Serotonin receptor 2A gene moderates the effect of childhood maternal nurturance on adulthood social attachment. Genes Brain Behav (2011) 0.82
A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci (2001) 0.82
Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster. Acta Neurol Scand (2000) 0.82
Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions. Scand J Clin Lab Invest (2006) 0.82
Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet (1998) 0.81
Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies. Br J Obstet Gynaecol (1998) 0.81
Breast feeding in infancy and arterial endothelial function later in life. The Cardiovascular Risk in Young Finns Study. Eur J Clin Nutr (2008) 0.81